Table 1.
Description of participants.
| Non-early seroconverter | High VL | Low VL | Control | |
|---|---|---|---|---|
| n = 20 | n = 20 | n = 22 | n = 9 | |
| Gender (female), n (%) | 11 (55) | 12 (60) | 18 (82) | 5 (56) |
| Age (years), median [IQR] | 45 [36-54] | 37 [27-51] | 40 [30-54] | 47 [32-52] |
| Type of contact with index case, n (%) | ||||
| Household contact | 9 (45) | 1 (5) | 1 (5) | 5 (56) |
| Healthcare worker | 4 (20) | 18 (90) | 17 (77) | 4 (44) |
| Nursing home worker | 7 (35) | 0 (0) | 3 (14) | 0 (0) |
| Unknown | 0 (0) | 1 (5) | 1 (5) | 0 (0) |
| Coexisting disease and other factors, n (%) | ||||
| None | 8 (40) | 15 (75) | 12 (54) | 1 (11) |
| Smoker | 5 (25) | 1 (5) | 1 (5) | 5 (56) |
| HT or Dyslipidemia | 4 (20) | 0 (0) | 5 (22) | 1 (11) |
| Obesity or DM | 3 (15) | 0 (0) | 5 (22) | 3 (33) |
| Respiratory disease | 3 (15) | 4 (20) | 1 (5) | 1 (11) |
| Autoimmune disease | 0 (0) | 0 (0) | 1 (5) | 0 (0) |
| Clinical presentation | ||||
| Symptoms (yes), n (%) | 5 (25) | 19 (95) | 19 (86) | — |
IQR, interquartile range (25th and 75th percentiles).